MALIGNANT METASTATIC INSULINOMA TREATED WITH STREPTOZOTOCIN.
- 1 September 1975
- journal article
- case report
- Published by Wiley in Clinical Endocrinology
- Vol. 4 (5) , 461-468
- https://doi.org/10.1111/j.1365-2265.1975.tb01555.x
Abstract
A patient with metastatic insulinoma who suffered from severe hypoglycaemic attacks was treated with 7-5 g of streptozotocin (Upjohn). Shortly after the start of treatment, the hypoglycaemic attacks ceased; fasting blood glucose levels and serum immunoreactive insulin values returned to normal upon completion of the treatment. Two years after treatment, the patient is well and active and has not had any attacks. The oral glucose tolerance test and tolbutamide stimulation test now show serum immunoreactive insulin excretion patterns similar to those seen in diabetics.Keywords
This publication has 18 references indexed in Scilit:
- The Use of Insulin Dynamics in the Evaluation of Streptozotocin Therapy of Malignant Insulinomas1Journal of Clinical Endocrinology & Metabolism, 1971
- Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinomaGut, 1971
- THERAPIE EINES METASTASIERENDEN INSELZELLTUMORS MIT STREPTOZOTOCINActa Endocrinologica, 1971
- Effect of Streptozotocin on Qualitative Aspects of Plasma Insulin in a Patient with a Malignant Islet Cell TumorJournal of Clinical Endocrinology & Metabolism, 1970
- TREATMENT OF INSULINOMA WITH STREPTOZOTOCINThe Lancet, 1969
- TREATMENT OF MULTIPLE-HORMONE-PRODUCING MALIGNANT ISLET-CELL TUMOUR WITH STREPTOZOTOCINThe Lancet, 1968
- Islet Cell Tumors of the PancreasAnnals of Internal Medicine, 1968
- Clinical Use of Diazoxide and Mechanism for Its Hyperglycemic EffectsDiabetes, 1966
- Insulin Secreting Tumors of the PancreasAnnals of Surgery, 1964
- ALLOXAN IN THE TREATMENT OF A CASE OF ISLET CELL CARCINOMA OF THE PANCREAS WITH LIVER METASTASESAnnals of Internal Medicine, 1947